Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Jun 30, 2025 | (FY)Jun 30, 2024 | (FY)Jun 30, 2023 | (FY)Jun 30, 2022 | (FY)Jun 30, 2021 | (FY)Jun 30, 2020 | (FY)Jun 30, 2019 | (FY)Jun 30, 2018 | |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow (direct method) | ||||||||
| Cash income from operating activities | -31.43%27.11K | -89.39%39.54K | 117.93%372.59K | 170.97K | ||||
| Revenue from customers | ---- | ---- | ---- | 117.93%372.59K | --170.97K | ---- | ---- | ---- |
| Other cash income from operating activities | ---- | -31.43%27.11K | --39.54K | ---- | ---- | ---- | ---- | ---- |
| Cash paid | -96.94%-501.76K | 69.52%-254.77K | 74.97%-835.79K | -10.25%-3.34M | -263.35%-3.03M | 69.12%-833.53K | -122.75%-2.7M | -1.21M |
| Payments to suppliers for goods and services | -96.94%-501.76K | 69.52%-254.77K | 59.29%-835.79K | -19.99%-2.05M | -290.26%-1.71M | 44.71%-438.49K | 6.68%-793.09K | ---849.83K |
| Other cash payments from operating activities | ---- | ---- | ---- | 2.40%-1.29M | -233.48%-1.32M | 79.28%-395.04K | -426.61%-1.91M | ---361.97K |
| Direct interest paid | ---- | ---- | 23.80%-8.24K | -38.09%-10.82K | -286.91%-7.84K | -868.90%-2.03K | ---209 | ---- |
| Direct interest received | 122.23%10.96K | -40.35%4.93K | 869.05%8.27K | -81.68%853 | -25.96%4.66K | -85.01%6.29K | 430.14%41.97K | --7.92K |
| Operating cash flow | -120.36%-490.8K | 72.03%-222.73K | 73.25%-796.23K | -4.04%-2.98M | -244.99%-2.86M | 68.80%-829.26K | -120.74%-2.66M | ---1.2M |
| Investing cash flow | ||||||||
| Cash flow from continuing investing activities | 69.23%-176.37K | 8.10%-573.1K | -83.89%-623.6K | 70.65%-339.12K | -3,665.57%-1.16M | 90.28%-30.68K | -315.6K | |
| Capital expenditure reported | 67.12%-193.64K | 31.51%-588.9K | ---859.85K | ---- | ---- | ---- | ---- | ---- |
| Net PPE purchase and sale | 9.32%17.27K | -93.31%15.8K | 163.88%236.25K | 67.99%-369.84K | -2,470.82%-1.16M | 85.72%-44.94K | ---314.6K | ---- |
| Net other investing changes | ---- | ---- | ---- | --30.72K | ---- | --14.26K | ---- | ---- |
| Cash from discontinued investing activities | ||||||||
| Investing cash flow | 69.23%-176.37K | 8.10%-573.1K | -83.89%-623.6K | 70.65%-339.12K | -3,665.57%-1.16M | 90.28%-30.68K | ---315.6K | ---- |
| Financing cash flow | ||||||||
| Cash flow from continuing financing activities | 2.14M | 0 | -70.32%1.26M | 4.24%4.25M | 1,440.81%4.07M | 3,036.05%264.3K | -100.19%-9K | 4.64M |
| Net issuance payments of debt | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Net common stock issuance | --2.14M | ---- | -69.49%1.31M | 4.59%4.28M | 1,449.45%4.1M | 3,036.05%264.3K | -100.19%-9K | --4.64M |
| Net other financing activities | ---- | ---- | -23.19%-93.2K | -65.63%-75.66K | ---45.68K | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||
| Financing cash flow | --2.14M | --0 | -70.32%1.26M | 4.24%4.25M | 1,440.81%4.07M | 3,036.05%264.3K | -100.19%-9K | --4.64M |
| Net cash flow | ||||||||
| Beginning cash position | -88.74%100.97K | -15.13%896.8K | 732.90%1.06M | 79.73%126.87K | -89.41%70.59K | -81.74%666.22K | 1,615.03%3.65M | --212.73K |
| Current changes in cash | 284.50%1.47M | -397.84%-795.83K | -117.19%-159.86K | 1,552.08%929.79K | 109.45%56.28K | 80.03%-595.64K | -186.80%-2.98M | --3.44M |
| End cash Position | 1,454.25%1.57M | -88.74%100.97K | -15.13%896.8K | 732.90%1.06M | 79.73%126.87K | -89.41%70.59K | -81.74%666.22K | --3.65M |
| Free cash from | 15.67%-684.44K | 51.04%-811.63K | 50.46%-1.66M | 16.68%-3.35M | -357.03%-4.02M | 70.44%-878.74K | -146.96%-2.97M | ---1.2M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |